NCT03914664

Brief Summary

The most pervasive sensory manifestation of TS is sensory over-responsivity (SOR). SOR is defined as excessive behavioral response to commonplace environmental stimuli. SOR is an integral but poorly understood facet of the TS phenotype, one intertwined with core elements of the disorder and worse QOL. This proposal seeks to clarify the mechanistic bases of SOR in TS. Adults with with TS will be recruited 1) to complete a standardized clinical symptom assessment battery and 2) to undergo electroencephalogram (EEG), autonomic, and audio-visual monitoring during tactile and auditory stimuli paradigms, as well as at rest.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
10mo left

Started Jul 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jul 2021Feb 2027

First Submitted

Initial submission to the registry

April 11, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
2.3 years until next milestone

Study Start

First participant enrolled

July 20, 2021

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

January 14, 2026

Status Verified

January 1, 2026

Enrollment Period

5.6 years

First QC Date

April 11, 2019

Last Update Submit

January 12, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Network oscillations in response to sensory stimuli

    Neural activity captured on EEG can be spectrally decomposed into various frequency constituencies. Neural activity in the gamma frequency range, so-called gamma band oscillations (GBOs), are associated with sensory processing and integration and are postulated to underlie sensory phenomena in TS.

    Baseline

  • Heart rate variability

    Change beat-to-beat variability in heart rate

    Baseline

  • Electrodermal activity in response to sensory stimuli

    Sweat response changes within 1-3 seconds of non-aversive sensory stimulus

    Baseline

Secondary Outcomes (12)

  • Premonitory Urge to Tic Scale (PUTS)

    Within 1 week of baseline

  • Yale Global Tic Severity Scale (YGTSS)

    Within 1 week of baseline

  • Dimensional Obsessive Compulsive Scale (DOCS)

    Within 1 week of baseline

  • Adult ADHD Self-Report Screening Scale

    Within 1 week of baseline

  • Generalized Anxiety Disorder 7 (GAD-7)

    Within 1 week of baseline

  • +7 more secondary outcomes

Study Arms (2)

Tourette Syndrome

Adults (\>18 years of age) with diagnosis of Tourette syndrome

Diagnostic Test: Electroencephalogram (EEG) testing procedureDiagnostic Test: Autonomic function testing procedure

Healthy Control

Adults who are generally healthy with no known neurologic or psychiatric diagnoses

Diagnostic Test: Electroencephalogram (EEG) testing procedureDiagnostic Test: Autonomic function testing procedure

Interventions

EEG testing procedure, comprised of somatosensory and auditory event-related potential paradigms, as well as resting state EEG

Healthy ControlTourette Syndrome

Autonomic function testing procedure, comprised of electrodes to determine heart rate variability and electrodermal activity (EDA)

Healthy ControlTourette Syndrome

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The two groups of participants will include: 1. adult with Tourette syndrome or other chronic tic disorder 2. healthy controls

You may qualify if:

  • Diagnosis of Tourette syndrome or other chronic tic disorder
  • ≥ 18 years of age
  • Ability to complete survey instruments
  • English fluency (given that all scales are validated in English)

You may not qualify if:

  • \- Known diagnosis of autism spectrum disorder, developmental delay, cerebral palsy, other significant neurologic disease, schizophrenia, or psychotic disorders will be excluded, in order to lessen potentially confounding factors.
  • (Note: Patients with OCD, ADHD, anxiety, and/or depression will be permitted, given that these diagnoses are widely prevalent in the adult TS population.)
  • Use of anti-seizure medications, stimulants, or other psychotropic medications known to alter EEG signal
  • Recreational substance use within past 30 days
  • ≥ 18 years of age AND age within 5 years of a participant in the TS arm of same biological sex (for purposes of age- and sex-matching)
  • Ability to complete survey instruments
  • English fluency (given that all scales are validated in English)
  • Any neurologic or psychiatric diagnoses
  • History of tics
  • Use of any psychotropic medications within the past 30 days
  • Recreational substance use within past 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232-5400, United States

Location

MeSH Terms

Conditions

Tourette SyndromeSensation DisordersHypersensitivityTics

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsImmune System DiseasesDyskinesias

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 11, 2019

First Posted

April 16, 2019

Study Start

July 20, 2021

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

February 28, 2027

Last Updated

January 14, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

De-identified clinical variables, EEG data, and autonomic data metrics may be shared with other researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The above information will be available for sharing within 6 months of publication.
Access Criteria
Researchers wishing to access the above information should contact the investigative team and provide: 1) hypothesis-driven scientific question for which the data will be analyzed and 2) proposed methods for responsibly analyzing the data.

Locations